Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation

about

Effect of anti-VEGF drugs combined with photodynamic therapy in the treatment of age-related macular degeneration.

P2860

Q41430488-F56438CA-EBA8-4D17-8F9D-DDF5C2F99AD5

P2860

Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation

Item

http://www.wikidata.org/entity/Q36864176

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Different Strategies for the T ...... China: An Economic Evaluation

@en

type

Item

label

Different Strategies for the T ...... China: An Economic Evaluation

@en

prefLabel

Different Strategies for the T ...... China: An Economic Evaluation

@en

P1476

Different Strategies for the T ...... China: An Economic Evaluation

@en

P2093

Houwen Lin

http://www.w3.org/2001/XMLSchema#string

Jin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Shanghai eye treatment outbreak: bevacizumab therapy for AMD in China

Ranibizumab for neovascular age-related macular degeneration

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

The cost-utility of photodynamic therapy in eyes with neovascular macular degeneration--a value-based reappraisal with 5-year data.

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom.

Prevalence of patients presenting with neovascular age-related macular degeneration in an urban population.

[Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].

P304

7689862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/7689862

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Bin Wu

Haixiang Wu

P577

2016-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301572267

http://www.w3.org/2001/XMLSchema#string

P698

27200183

http://www.w3.org/2001/XMLSchema#string

P932

4855017

http://www.w3.org/2001/XMLSchema#string

Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation

about

P2860

P2860

Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932